CUSIP: 72940R102
Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,595,812
-
Share change
-
-277,951
-
Total reported value
-
$3,711,000
-
Put/Call ratio
-
93%
-
Price per share
-
$1.43
-
Number of holders
-
27
-
Value change
-
-$515,837
-
Number of buys
-
10
-
Number of sells
-
13
Quarterly Holders Quick Answers
What is CUSIP 72940R102?
CUSIP 72940R102 identifies PSTI - PLURISTEM THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2017
-
Previous quarter:
Q3 2016
Recent filing periods for CUSIP 72940R102:
Institutional Holders of PLURISTEM THERAPEUTICS INC - COM (PSTI) as of Q4 2016
As of 31 Dec 2016,
PLURISTEM THERAPEUTICS INC - COM (PSTI) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,595,812 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, UBS Group AG, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, OPPENHEIMER & CO INC, JANE STREET GROUP, LLC, Harel Insurance Investments & Financial Services Ltd., HighTower Advisors, LLC, Psagot Investment House Ltd., VAN ECK ASSOCIATES CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.